Imperial College London

Professor Amanda Cross

Faculty of MedicineSchool of Public Health

Professor of Cancer Epidemiology



+44 (0)20 7594 3338amanda.cross




Mr Will Kay +44 (0)20 7594 3350




Norfolk PlaceSt Mary's Campus





Professor Cross is a cancer epidemiologist in the Department of Epidemiology and Biostatistics within the School of Public Health, Faculty of Medicine of Imperial College. She is also the Head of the Cancer Screening and Prevention Research Group ( the Department of Surgery and Cancer at Imperial.

She completed her PhD at Cambridge University and then obtained a post-doctoral fellowship within the Division of Cancer Epidemiology and Genetics (DCEG) at the National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, United States. After two years of post-doctoral research, Dr. Cross was awarded a research fellowship and shortly after became a tenure-track investigator at NCI. During her time as an investigator at NCI, she was also a mentor for the Yale University– NCI Partnership Training Program and held the position of Assistant Professor Adjunct within the Division of Chronic Disease Epidemiology at Yale University, New Haven, Connecticut.  Dr. Cross received the NIH Fellows Award for Research Excellence, the DCEG Fellowship Achievement Award for Outstanding Accomplishments, the DCEG Award for Outstanding Research Paper by a Fellow, the NCI Mentor of Merit Award, and the NIH Merit Award for Leadership of an Innovative Multidisciplinary Research Program.

Between 2005 and 2013, Dr. Cross was Principal Investigator of two colonoscopy screening studies (the Polyp Prevention Trial and the CONCeRN study), a metabolomics initiative within DCEG, and she was also one of the Principal Investigators of the U.S. Polyp Pooling Project. In 2013, Dr. Cross joined Imperial College to pursue her research interests in gastrointestinal malignancies and etiologic studies of lifestyle factors and cancer risk.



Charvat H, Freisling H, Noh H, et al., 2021, Excess body fatness during early to mid-adulthood and survival from colorectal and breast cancer: a pooled analysis of five international cohort studies., Cancer Epidemiol Biomarkers Prev

Bretthauer M, Schoen RE, Cross AJ, et al., 2021, Colorectal Cancer Screening: Randomized Trials are Essential to Support Recommendations., Ann Intern Med

Baker JR, Umesh S, Jenab M, et al., 2021, Prediagnostic blood selenium status and mortality among patients with colorectal cancer in Western European populations, Biomedicines, Vol:9, ISSN:2227-9059, Pages:1-15

Rothwell JA, Jenab M, Karimi M, et al., 2021, Metabolic syndrome and risk of gastrointestinal cancers: an investigation using large-scale molecular data, Clinical Gastroenterology and Hepatology, ISSN:1542-3565

Cross AJ, Robbins EC, 2021, Reply, Clinical Gastroenterology and Hepatology, Vol:19, ISSN:1542-3565, Pages:2217-2218

More Publications